These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35670972)

  • 21. Efficient siRNA Delivery by Lipid Nanoparticles Modified with a Nonstandard Macrocyclic Peptide for EpCAM-Targeting.
    Sakurai Y; Mizumura W; Murata M; Hada T; Yamamoto S; Ito K; Iwasaki K; Katoh T; Goto Y; Takagi A; Kohara M; Suga H; Harashima H
    Mol Pharm; 2017 Oct; 14(10):3290-3298. PubMed ID: 28789523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging of cationic multifunctional liposome-mediated delivery of COX-2 siRNA.
    Mikhaylova M; Stasinopoulos I; Kato Y; Artemov D; Bhujwalla ZM
    Cancer Gene Ther; 2009 Mar; 16(3):217-26. PubMed ID: 18927599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zwitterionic poly(carboxybetaine)-based cationic liposomes for effective delivery of small interfering RNA therapeutics without accelerated blood clearance phenomenon.
    Li Y; Liu R; Shi Y; Zhang Z; Zhang X
    Theranostics; 2015; 5(6):583-96. PubMed ID: 25825598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dicetyl phosphate-tetraethylenepentamine-based liposomes for systemic siRNA delivery.
    Asai T; Matsushita S; Kenjo E; Tsuzuku T; Yonenaga N; Koide H; Hatanaka K; Dewa T; Nango M; Maeda N; Kikuchi H; Oku N
    Bioconjug Chem; 2011 Mar; 22(3):429-35. PubMed ID: 21361311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Development of an efficient short interference RNA (siRNA) delivery system with a new pH-sensitive cationic lipid].
    Sato Y; Hatakeyama H; Hyodo M; Akita H; Harashima H
    Yakugaku Zasshi; 2012; 132(12):1355-63. PubMed ID: 23208041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RGD-based active targeting of novel polycation liposomes bearing siRNA for cancer treatment.
    Yonenaga N; Kenjo E; Asai T; Tsuruta A; Shimizu K; Dewa T; Nango M; Oku N
    J Control Release; 2012 Jun; 160(2):177-81. PubMed ID: 22019557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nucleic Acid Delivery System by the Combination of Lipid bubbles and Ultrasound.
    Endo-Takahashi Y; Maruyama K; Negishi Y
    Curr Pharm Des; 2018; 24(23):2673-2677. PubMed ID: 30084324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced endosomal/lysosomal escape by distearoyl phosphoethanolamine-polycarboxybetaine lipid for systemic delivery of siRNA.
    Li Y; Cheng Q; Jiang Q; Huang Y; Liu H; Zhao Y; Cao W; Ma G; Dai F; Liang X; Liang Z; Zhang X
    J Control Release; 2014 Feb; 176():104-14. PubMed ID: 24365128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficient Biodistribution and Gene Silencing in the Lung epithelium via Intravenous Liposomal Delivery of siRNA.
    McCaskill J; Singhania R; Burgess M; Allavena R; Wu S; Blumenthal A; McMillan NA
    Mol Ther Nucleic Acids; 2013 Jun; 2(6):e96. PubMed ID: 23736774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a novel method for formulating stable siRNA-loaded lipid particles for in vivo use.
    Wu SY; Putral LN; Liang M; Chang HI; Davies NM; McMillan NA
    Pharm Res; 2009 Mar; 26(3):512-22. PubMed ID: 19023647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
    Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC
    J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery.
    Haghiralsadat F; Amoabediny G; Helder MN; Naderinezhad S; Sheikhha MH; Forouzanfar T; Zandieh-Doulabi B
    Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):169-177. PubMed ID: 28376641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene silencing via RNAi and siRNA quantification in tumor tissue using MEND, a liposomal siRNA delivery system.
    Sakurai Y; Hatakeyama H; Sato Y; Hyodo M; Akita H; Harashima H
    Mol Ther; 2013 Jun; 21(6):1195-203. PubMed ID: 23568259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PEGylated hyaluronic acid-modified liposomal delivery system with anti-γ-glutamylcyclotransferase siRNA for drug-resistant MCF-7 breast cancer therapy.
    Ran R; Liu Y; Gao H; Kuang Q; Zhang Q; Tang J; Fu H; Zhang Z; He Q
    J Pharm Sci; 2015 Feb; 104(2):476-84. PubMed ID: 25256603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cationic lipids and polymers mediated vectors for delivery of siRNA.
    Zhang S; Zhao B; Jiang H; Wang B; Ma B
    J Control Release; 2007 Oct; 123(1):1-10. PubMed ID: 17716771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation and Characterization of siRNA-Loaded Liposomes.
    Liu Y; Huang L
    Methods Mol Biol; 2021; 2282():159-169. PubMed ID: 33928575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic delivery of E6/7 siRNA using novel lipidic particles and its application with cisplatin in cervical cancer mouse models.
    Wu SY; Singhania A; Burgess M; Putral LN; Kirkpatrick C; Davies NM; McMillan NA
    Gene Ther; 2011 Jan; 18(1):14-22. PubMed ID: 20703312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes.
    Bender HR; Kane S; Zabel MD
    J Vis Exp; 2016 Jul; (113):. PubMed ID: 27501362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cationic Liposome- Multi-Walled Carbon Nanotubes Hybrids for Dual siPLK1 and Doxorubicin Delivery In Vitro.
    Pereira S; Lee J; Rubio N; Hassan HA; Suffian IB; Wang JT; Klippstein R; Ballesteros B; Al-Jamal WT; Al-Jamal KT
    Pharm Res; 2015 Oct; 32(10):3293-308. PubMed ID: 26085038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Co-delivery of curcumin and STAT3 siRNA using deformable cationic liposomes to treat skin cancer.
    Jose A; Labala S; Venuganti VV
    J Drug Target; 2017 Apr; 25(4):330-341. PubMed ID: 27819148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.